Tremor in Parkinson’s Disease: From Pathophysiology to Advanced Therapies
Tremor and Other Hyperkinetic Movements · 2022-09-13 · 12 (1)
DOI: 10.5334/tohm.712 ↗At a glance
Übersichtsarbeit in Tremor and Other Hyperkinetic Movements, published on 2022-09-13. Written by Ali H Abusrair and 2 co-authors. Institution: Department of Clinical Neurosciences, Faculty of Medicine, University of Calgary, Calgary, AB, Canada. Major MEDLINE topics: Botulinum Toxins, Parkinson Disease. Cited 94 times so far (Crossref); 169 references. The full text is freely available in PubMed Central.
Abstract (original language)
Background
Tremor is one of the most prevalent symptoms in Parkinson’s Disease (PD). The progression and management of tremor in PD can be challenging, as response to dopaminergic agents might be relatively poor, particularly in patients with tremor-dominant PD compared to the akinetic/rigid subtype. In this review, we aim to highlight recent advances in the underlying pathogenesis and treatment modalities for tremor in PD.
Methods
A structured literature search through Embase was conducted using the terms “Parkinson’s Disease” AND “tremor” OR “etiology” OR “management” OR “drug resistance” OR “therapy” OR “rehabilitation” OR “surgery.” After initial screening, eligible articles were selected with a focus on published literature in the last 10 years.
Discussion
The underlying pathophysiology of tremor in PD remains complex and incompletely understood. Neurodegeneration of dopaminergic neurons in the retrorubral area, in addition to high-power neural oscillations in the cerebello-thalamo-cortical circuit and the basal ganglia, play a major role. Levodopa is the first-line therapeutic option for all motor symptoms, including tremor. The addition of dopamine agonists or anticholinergics can lead to further tremor reduction. Botulinum toxin injection is an effective alternative for patients with pharmacological-resistant tremor who are not seeking advanced therapies. Deep brain stimulation is the most well-established advanced therapy owing to its long-term efficacy, reversibility, and effectiveness in other motor symptoms and fluctuations. Magnetic resonance-guided focused ultrasound is a promising modality, which has the advantage of being incisionless. Cortical and peripheral electrical stimulation are non-invasive innovatory techniques that have demonstrated good efficacy in suppressing intractable tremor.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Clinical Neurosciences, Faculty of Medicine, University of Calgary, Calgary, AB, Canada.
- Division of Neurology, Department of Internal Medicine, Qatif Health Network, Qatif, Saudi Arabia.
- College of Medicine, AlFaisal University, Riyadh, Saudi Arabia.
- Movement Disorders Program, Neurosciences Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
ORCID profiles: Ali H Abusrair, Walaa Elsekaily, Saeed Bohlega
Cite
APA
Abusrair, A. H., Elsekaily, W., & Bohlega, S. (2022). Tremor in Parkinson’s Disease: From Pathophysiology to Advanced Therapies. Tremor and Other Hyperkinetic Movements, 12(1). https://doi.org/10.5334/tohm.712
Vancouver
Abusrair AH, Elsekaily W, Bohlega S. Tremor in Parkinson’s Disease: From Pathophysiology to Advanced Therapies. Tremor and Other Hyperkinetic Movements. 2022;12(1). doi:10.5334/tohm.712
BibTeX
@article{Abusrair2022,
author = {Abusrair, Ali H and Elsekaily, Walaa and Bohlega, Saeed},
title = {Tremor in Parkinson’s Disease: From Pathophysiology to Advanced Therapies},
journal = {Tremor and Other Hyperkinetic Movements},
year = {2022},
volume = {12},
number = {1},
doi = {10.5334/tohm.712}
}
EUVIMED